Award Data

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to increase access to and compliance with cardiac rehabilitation program and reduce the cost of avoidable hospital readmission, both by predicting which cardiac patients are at risk and by providing patients with simple but accurate guidance, allowing them to precisely control exercise inte ...

This Small Business Innovation Research Phase I project intends to improve upon the surface characteristics of stainless steel in demanding environments. Particularly, it may constitute a significant improvement in the field of Li-ion battery current collectors. Today, current collector metal corrodes during repeated cycling leading to diminished capacity and potential safety issues related to cel ...

This SBIR Phase I project addresses a critical need in medicine ? the ability to deliver drugs selectively to parts of the body that need medication. Targeted drug delivery improves patient outcomes by treating tissues locally while reducing overall exposure and side effects elsewhere. For example, a cream or lotion type product which moves anti-inflammatory drugs through skin specifically to an a ...

This SBIR Phase I project addresses the lack of materials available for advanced 3D printing. 3D printing is and will likely be used to produce products that encompass every aspect of day-to-day life. Current technology is primarily focused on the aerospace and medical fields. New metallic materials and more efficient processing methods are needed to transition to other more ubiquitous markets. Th ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a first-in-class patient education tool. The project aims to develop a method to customize and personalize the delivery of medical content with the goal of influencing medication compliance and health outcomes. Imagine patients are discharged from the hospital and underst ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is widespread adoption of a technology with a direct cost-­savings in healthcare. It is estimated that nearly 5,000 patients are harmed each year due to wrong-patient errors in medical imaging. Additionally, even a 10% improvement in efficiency in radiologists' performance would translate to ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies in its potential to develop a new mechanism for painlessly terminating atrial fibrillation. Cardiac arrhythmia is one of the leading causes of death and debilitation. A common means of terminating harmful rhythms is delivering a shock via an external or implantable defibrillator. The pain ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a hyper-personalized, clinical, and evidence-based blood transfusion decision support tool to reduce unnecessary transfusions, transfusion-related complications, and transfusion related expenditures. Blood transfusions are the most commonly prescribed medical procedure in the US, ...

The broader impact/commercial potential of this Small Business Innovation Research Phase I project is to improve respiratory protection against ammonia by using novel carbide-derived carbons (CDCs). The outcome of this project will improve the safety and health for industrial workers, firefighters, and first responders that encounter ammonia in industrial settings and emergency situations. Current ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of a novel compact cell settler that can selectively remove dead cells and cell debris from the cell culture broth and completely recycle all the live and productive cells back to the continuous perfusion bioreactor. As this membrane-free device is not prone to clogging like the com ...